Echocardiographic parameters in reversible idiopathic dilated cardiomyopathy

American Journal of the Medical Sciences

Volumn 319, Issue 6, 2000, Pages 366-369

  Khanlou, Homayoun ^a,c   Paltoo, Brendon ^b   Forbes, Winston ^b  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

^b WASHINGTON HOSPITAL CENTER   (United States)

^c AHF Research Center   (United States)

Author keywords

Idiopathic dilated cardiomyopathy; Left ventricular diameter; Reversible cardiomyopathy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MALE; PREDICTION; PROGNOSIS; SYSTOLE;

EID: 0034097977     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200006000-00004     Document Type: Article

References (24)

1. Dec WG, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994;331:1564-75.
2. Joshua W, Braunwald E. The cardiomyopathies and myocarditides. In: Braunwald E, editor. Textbook of cardiology. Philadelphia: WB Saunders; 1997. p. 1404-63.
3. Packer M, Gottlieb SS, Blum MA. Immediate and long term pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure. Am J Med 1987;82:4-10.
4. Werner GS, Schaefer C, Dirks R, et al. Prognostic value of Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy. Am J Cardiol 1994; 73:792-8.
5. Johnson RA, Palacios I. Dilated cardiomyopathies of the adult. N Engl J Med 1982;307:1051-8.
6. Folland ED, Parisi AF, Moynihan PF, et al. Assessment of left ventricular ejection fraction and volumes by real-time, two-dimensional echocardiography. Circulation 1979;60:760-6.
7. Quinones MA, Pickering E, Alexander JA. Percentage of shortening of the echocardiographic left ventricular dimension: Its use in determining ejection fraction and stroke volume. Chest 1978;74:59-65.
8. Fuster V, Gersh BJ, Giuliani ER, et al. The natural history of idiopathic dilated cardiomyopathy. Am J Cardiol 1981;47:525-31.
9. Werner GS, Schaefer C, Dirks R, et al. Doppler echocardiographic assessment of left ventricular filling in idiopathic dilated cardiomyopathy during a one-year follow-up: relation to the clinical course of disease. Am Heart J 1993;126:1408-16.
10. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326: 77-82.
11. Dec GW Jr, Palacios IF, Fallon JT, et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies: clinical features, histologic correlates, and clinical outcome. N Engl J Med 1985;312:885-90.
12. Gerli R, Rambotti P, Spinozzi F, et al. Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy. Am Heart J 1986;112:350-5.
13. Bristow MR, Anderson FL, Port JD, et al. Differences in β adrenergic neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991;84:1024-39.
14. Sugrue DD, Rodeheffer RJ, Codd MB, et al. The clinical course of idiopathic dilated cardiomyopathy: a population-based study. Ann Intern Med 1992;117:117-23.
15. Di Lenarda A, Lardieri G, Mestroni L, et al. Dilated cardiomyopathy: changing survival in the last 20 years [abstract]. Circulation 1990;82(Suppl 3):387.
16. Rihal CS, Nishimura RA, Hatle LK, et al. Systolic and diastolic dysfunction in patients with clinical diagnosis of dilated cardiomyopathy: relation to symptoms and prognosis. Circulation 1994;90:2772-9.
17. Benjamin IJ, Schuster EH, Bulkley BH. Cardiac hypertrophy in idiopathic dilated congestive cardiomyopathy: a clinicopathologic study. Circulation 1981;64:442-7.
18. Carlquist JF, Menlove RL, Murray MB, et al. HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy: validation study and meta-analysis of published HLA association studies. Circulation 1992;83:515-22.
19. Kim MH, Starling MR. Effects of β-blockade on left ventricular diastolic function in patients with dilated congestive cardiomyopathy [abstract]. Circulation 1994;90:I-543.
20. Hall S, Cigarroa C, Marcoux L, et al. Time course of left ventricular function improvement in patients with congestive heart failure treated with β adrenergic blockade [abstract]. Circulation 1994;90:I-543.
21. Rahman MA, Hara K, Daly PA, et al. Reductions in muscle sympathetic nerve activity after long term metoprolol for dilated cardiomyopathy: preliminary observation. Br Heart J 1995;74:431-6.
22. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: metoprolol in dilated cardiomyopathy (MDC) trial study group. Lancet 1993;342:1441-6.
23. Australia/New-Zealand Heart failure Research Collaborative Group. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 1997;349:375-80.
24. Levin HR, Oz Mc, Chen JM, et al. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 1995;91: 2717-20.